Quest upgraded while Teva downgraded at UBS, and VectiveBio scores two new buy initiations in today's analyst action - ADVFN
Teva's collapse – Israel's biotech recovery - The Jerusalem Post
UBS cuts estimate of Teva's opioid liability - Globes
Storbank blåstempler Kåre Schultz' plan for Teva: Aktien er »for billig til at ignorere«
UBS nedjusterer Teva Pharmaceuticals efter Kåre Schultz indgår forlig i USA
UBS raises Teva price target - Globes
UBS raises Teva price target - Globes
Teva stock downgraded to neutral by UBS on heels of $85 million opioid settlement - MarketWatch
Stock Picks to Buy, 13 Contrarian Names and Rationale for Each: UBS
Most Active Foreign Bonds 21.05.2021 – Teva Pharma, Gazprom, New York Life, Deutsche Bahn, Russian Railways, UBS London Branch – Financial Markets Blog
Teva completes $3.2b acquisition of Auspex - Globes
Watch What You Need to Know: China, UBS, TEVA - Bloomberg
Most Active Foreign Bonds 21.05.2021 – Teva Pharma, Gazprom, New York Life, Deutsche Bahn, Russian Railways, UBS London Branch – Financial Markets Blog
Teva Pharmaceutical Industries Stock Jumps on a Rare Bullish View | Barron's
UBS — EMMA KOLB
UBS: Tvivl om størrelse på mulig erstatning i Teva-sager - kan løbe op i større milliardbeløb
Rhode Island takes Teva to trial in multibillion-dollar opioid case | Nasdaq
Rebounding Teva is 'too cheap to ignore,' upbeat analysts say | Fierce Pharma
Teva shares hit 19-year low after opioid settlement, analyst downgrades | Fierce Pharma
Teva's Legal Overhang Triggers UBS Downgrade, Near-Halving Of Price Target
Teva jumps after Wall Street upgrades, analysts say stock 'too cheap to ignore'
UBS reiterates Teva's Buy rating but cuts price target - Globes
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Generic Drug Lawsuit Could Mean Big Fines for Teva, Mylan: UBS
